Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Die Folgen des Klimwandels haben einen direkten Einfluss auf die Primärversorgung in Deutschland: Hitzeschutz insbesondere bei älteren Patienten, die Zunahme von Infektionen und die Verlängerung der Allergiesesaison spielen medizinisch eine bedeutsame Rolle. Aber auch in der Prävention und der Aufklärung der Patienten kommt den Hausärztinnen und -ärzten eine besondere Rolle zu. Direkt aus der Praxis berichtet im Live-Webinar am 13. Mai von 18 bis 19 Uhr unser Experte Dr. med. Robin Maitra.
Erweiterte Suche
Anmelden
nach oben
Current Diabetes Reports
Erschienen in: Current Diabetes Reports 6/2013

01.12.2013 | Diabetes Epidemiology (SH Golden, Section Editor)

Race/Ethnic Difference in Diabetes and Diabetic Complications

verfasst von: Elias K. Spanakis, Sherita Hill Golden

Erschienen in: Current Diabetes Reports | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Health disparities in diabetes and its complications and comorbidities exist globally. A recent Endocrine Society Scientific Statement described the Health Disparities in several endocrine disorders, including type 2 diabetes. In this review, we summarize that statement and provide novel updates on race/ethnic differences in children and adults with type 1 diabetes, children with type 2 diabetes, and in Latino subpopulations. We also review race/ethnic differences in the epidemiology of diabetes, prediabetes, and diabetes complications and mortality in the United States and globally. Finally, we discuss biological, behavioral, social, environmental, and health system contributors to diabetes disparities to identify areas for future preventive interventions.
Literatur
1.
•• Golden SH, Brown A, Cauley JA, Chin MH, Gary-Webb TL, Kim C, et al. Health disparities in endocrine disorders: biological, clinical, and nonclinical factors--an Endocrine Society scientific statement. J Clin Endocrinol Metab. 2012;97(9):E1579–639. doi:10.​1210/​jc.​2012-2043. This study provides the most comprehensive overview of race/ethnic disparities in diabetes mellitus and its complications, the biological, clinical, and nonclinical contributors to diabetes disparities, and a conceptual framework to consider interventions to reduce and/or eliminate diabetes disparities.PubMedCrossRef
2.
Williams DR. Race and health: basic questions, emerging directions. Ann Epidemiol. 1997;7(5):322–33.PubMedCrossRef
3.
Karter AJ. Commentary: Race, genetics, and disease–in search of a middle ground. Int J Epidemiol. 2003;32(1):26–8.PubMedCrossRef
4.
Karter AJ. Race and ethnicity: vital constructs for diabetes research. Diabetes Care. 2003;26(7):2189–93.PubMedCrossRef
5.
6.•
Daviglus ML, Talavera GA, Aviles-Santa ML, Allison M, Cai J, Criqui MH, et al. Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States. JAMA. 2012;308(17):1775–84. doi:10.​1001/​jama.​2012.​14517. This study provides the first population-based data on the distribution of diabetes and obesity among Latino sub-groups in the United States.PubMedCrossRef
7.
Barnes PM, Adams PF, Powell-Griner E. Health characteristics of the Asian adult population: United States, 2004–2006. Adv Data. 2008;394:1–22.PubMed
8.
9.
10.
Bell RA, Mayer-Davis EJ, Beyer JW, D'Agostino Jr RB, Lawrence JM, Linder B, et al. Diabetes in non-Hispanic white youth: prevalence, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth Study. Diabetes Care. 2009;32 Suppl 2:S102–11. doi:10.​2337/​dc09-S202.PubMedCrossRef
11.
Mayer-Davis EJ, Beyer J, Bell RA, Dabelea D, D'Agostino Jr R, Imperatore G, et al. Diabetes in African American youth: prevalence, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth Study. Diabetes Care. 2009;32 Suppl 2:S112–22. doi:10.​2337/​dc09-S203.PubMedCrossRef
12.
Lawrence JM, Mayer-Davis EJ, Reynolds K, Beyer J, Pettitt DJ, D'Agostino Jr RB, et al. Diabetes in Hispanic American youth: prevalence, incidence, demographics, and clinical characteristics: the SEARCH for Diabetes in Youth Study. Diabetes Care. 2009;32 Suppl 2:S123–32. doi:10.​2337/​dc09-S204.PubMedCrossRef
13.
Liu LL, Yi JP, Beyer J, Mayer-Davis EJ, Dolan LM, Dabelea DM, et al. Type 1 and Type 2 diabetes in Asian and Pacific Islander U.S. youth: the SEARCH for Diabetes in Youth Study. Diabetes Care. 2009;32 Suppl 2:S133–40. doi:10.​2337/​dc09-S205.PubMedCrossRef
14.
Dabelea D, DeGroat J, Sorrelman C, Glass M, Percy CA, Avery C, et al. Diabetes in Navajo youth: prevalence, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth Study. Diabetes Care. 2009;32 Suppl 2:S141–7. doi:10.​2337/​dc09-S206.PubMedCrossRef
15.
16.
Lanting LC, Joung IM, Mackenbach JP, Lamberts SW, Bootsma AH. Ethnic differences in mortality, end-stage complications, and quality of care among diabetic patients: a review. Diabetes Care. 2005;28(9):2280–8.PubMedCrossRef
17.
18.
Gentile NT, Seftchick MW. Poor outcomes in Hispanic and African American patients after acute ischemic stroke: influence of diabetes and hyperglycemia. Ethn Dis. 2008;18(3):330–5.PubMed
19.
Dagogo-Jack S. Ethnic disparities in type 2 diabetes: pathophysiology and implications for prevention and management. J Natl Med Assoc. 2003;95(9):774. 9–89.PubMed
20.
21.
Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV. Ethnic disparities in diabetic complications in an insured population. JAMA. 2002;287(19):2519–27.PubMedCrossRef
22.
Berinstein DM, Stahn RM, Welty TK, Leonardson GR, Herlihy JJ. The prevalence of diabetic retinopathy and associated risk factors among Sioux Indians. Diabetes Care. 1997;20(5):757–9.PubMedCrossRef
23.
Harris MI, Klein R, Cowie CC, Rowland M, Byrd-Holt DD. Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study. Diabetes Care. 1998;21(8):1230–5.PubMedCrossRef
24.
25.
26.
Sosenko JM. The prevalence of diabetic neuropathy according to ethnicity. Curr Diab Rep. 2009;9(6):435–9.PubMedCrossRef
27.
Haffner SM, D'Agostino R, Saad MF, Rewers M, Mykkanen L, Selby J, et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes. 1996;45(6):742–8.PubMedCrossRef
28.
Albu JB, Kovera AJ, Allen L, Wainwright M, Berk E, Raja-Khan N, et al. Independent association of insulin resistance with larger amounts of intermuscular adipose tissue and a greater acute insulin response to glucose in African American than in white nondiabetic women. Am J Clin Nutr. 2005;82(6):1210–7.PubMed
29.
Ferrannini E, Gastaldelli A, Matsuda M, Miyazaki Y, Pettiti M, Glass L, et al. Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis. J Clin Endocrinol Metab. 2003;88(7):3251–7.PubMedCrossRef
30.
Donahue RP, Bean JA, Donahue RA, Goldberg RB, Prineas RJ. Insulin response in a triethnic population: effects of sex, ethnic origin, and body fat. Miami Community Health Study. Diabetes Care. 1997;20(11):1670–6.PubMedCrossRef
31.
Torrens JI, Skurnick J, Davidow AL, Korenman SG, Santoro N, Soto-Greene M, et al. Ethnic differences in insulin sensitivity and beta-cell function in premenopausal or early perimenopausal women without diabetes: the Study of Women's Health Across the Nation (SWAN). Diabetes Care. 2004;27(2):354–61.PubMedCrossRef
32.
Chiu KC, Chuang LM, Yoon C. Comparison of measured and estimated indices of insulin sensitivity and beta cell function: impact of ethnicity on insulin sensitivity and beta cell function in glucose-tolerant and normotensive subjects. J Clin Endocrinol Metab. 2001;86(4):1620–5.PubMedCrossRef
33.
Jensen CC, Cnop M, Hull RL, Fujimoto WY, Kahn SE. American Diabetes Association GSG. Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S. Diabetes. 2002;51(7):2170–8.PubMedCrossRef
34.
Resnick HE, Bergman RN, Henderson JA, Nez-Henderson P, Howard BV. Utility of a surrogate measure of insulin resistance in American Indians: the Strong Heart Study. Ethn Dis. 2002;12(4):523–9.PubMed
35.
Nagulesparan M, Savage PJ, Knowler WC, Johnson GC, Bennett PH. Increased in vivo insulin resistance in nondiabetic Pima Indians compared with Caucasians. Diabetes. 1982;31(11):952–6.PubMedCrossRef
36.
37.
38.
39.•
Narayan KM, Aviles-Santa L, Oza-Frank R, Pandey M, Curb JD, McNeely M, et al. Report of a National Heart, Lung, And Blood Institute Workshop: heterogeneity in cardiometabolic risk in Asian Americans In the U.S. Opportunities for research. J Am Coll Cardiol. 2010;55(10):966–73. doi:10.​1016/​j.​jacc.​2009.​07.​075. This study summarizes ethnic differences in diabetes mellitus and obesity among Asian American subgroups.PubMedCrossRef
40.
41.
42.
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–53.CrossRef
43.
Kirk JK, Bell RA, Bertoni AG, Arcury TA, Quandt SA, Goff Jr DC, et al. Ethnic disparities: control of glycemia, blood pressure, and LDL cholesterol among US adults with type 2 diabetes. Ann Pharmacother. 2005;39(9):1489–501.PubMedCrossRef
44.
Kirk JK, D'Agostino Jr RB, Bell RA, Passmore LV, Bonds DE, Karter AJ, et al. Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes: a meta-analysis. Diabetes Care. 2006;29(9):2130–6.PubMedCrossRef
45.
Kirk JK, Passmore LV, Bell RA, Narayan KM, D'Agostino Jr RB, Arcury TA, et al. Disparities in A1C levels between Hispanic and non-Hispanic white adults with diabetes: a meta-analysis. Diabetes Care. 2008;31(2):240–6.PubMedCrossRef
46.
47.
48.
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403. doi:10.​1056/​NEJMoa012512.PubMedCrossRef
49.
50.
Kurian AK, Cardarelli KM. Racial and ethnic differences in cardiovascular disease risk factors: a systematic review. Ethn Dis. 2007;17(1):143–52.PubMed
51.
52.
Kirk JK, Graves DE, Bell RA, Hildebrandt CA, Narayan KM. Racial and ethnic disparities in self-monitoring of blood glucose among US adults: a qualitative review. Ethn Dis. 2007;17(1):135–42.PubMed
53.
Gonzalez JS, Peyrot M, McCarl LA, Collins EM, Serpa L, Mimiaga MJ, et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care. 2008;31(12):2398–403. doi:10.​2337/​dc08-1341.PubMedCrossRef
54.
Li C, Ford ES, Strine TW, Mokdad AH. Prevalence of depression among U.S. adults with diabetes: findings from the 2006 behavioral risk factor surveillance system. Diabetes Care. 2008;31(1):105–7.PubMedCrossRef
55.
Wagner J, Tsimikas J, Abbott G, de Groot M, Heapy A. Racial and ethnic differences in diabetic patient-reported depression symptoms, diagnosis, and treatment. Diabetes Res Clin Pract. 2007;75(1):119–22.PubMedCrossRef
56.
Heisler M, Faul JD, Hayward RA, Langa KM, Blaum C, Weir D. Mechanisms for racial and ethnic disparities in glycemic control in middle-aged and older Americans in the health and retirement study. Arch Intern Med. 2007;167(17):1853–60.PubMedCrossRef
57.
Karter AJ, Stevens MR, Brown AF, Duru OK, Gregg EW, Gary TL, et al. Educational disparities in health behaviors among patients with diabetes: the Translating Research Into Action for Diabetes (TRIAD) Study. BMC Public Health. 2007;7:308.PubMedCrossRef
58.
59.
60.
61.
Papas MA, Alberg AJ, Ewing R, Helzlsouer KJ, Gary TL, Klassen AC. The built environment and obesity. Epidemiol Rev. 2007;29:129–43.PubMedCrossRef
62.
Auchincloss AH, Diez Roux AV, Mujahid MS, Shen M, Bertoni AG, Carnethon MR. Neighborhood resources for physical activity and healthy foods and incidence of type 2 diabetes mellitus: the Multi-Ethnic study of Atherosclerosis. Arch Intern Med. 2009;169(18):1698–704. doi:10.​1001/​archinternmed.​2009.​302.PubMedCrossRef
63.
Auchincloss AH, Diez Roux AV, Brown DG, O'Meara ES, Raghunathan TE. Association of insulin resistance with distance to wealthy areas: the multi-ethnic study of atherosclerosis. Am J Epidemiol. 2007;165(4).
64.
Gary TL, Safford MM, Gerzoff RB, Ettner SL, Karter AJ, Beckles GL, et al. Perception of neighborhood problems, health behaviors, and diabetes outcomes among adults with diabetes in managed care: the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care. 2008;31(2):273–8.PubMedCrossRef
65.
Brown AF, Ang A, Pebley AR. The relationship between neighborhood characteristics and self-rated health for adults with chronic conditions. Am J Public Health. 2007;97(5):926–32.PubMedCrossRef
66.
Sooman A, Macintyre S, Anderson A. Scotland's health–a more difficult challenge for some? The price and availability of healthy foods in socially contrasting localities in the west of Scotland. Health Bull (Edinb). 1993;51(5):276–84.
67.
Morland K, Diez Roux AV, Wing S. Supermarkets, other food stores, and obesity: the atherosclerosis risk in communities study. Am J Prev Med. 2006;30(4):333–9. doi:S0749-3797(05)00483-6.
68.
Horowitz CR, Colson KA, Hebert PL, Lancaster K. Barriers to buying healthy foods for people with diabetes: evidence of environmental disparities. Am J Public Health. 2004;94(9):1549–54. doi:94/​9/​1549.
69.
Harris MI, Cowie CC, Eastman R. Health-insurance coverage for adults with diabetes in the U.S. population. Diabetes Care. 1994;17(6):585–91.PubMedCrossRef
70.
Harris MI. Racial and ethnic differences in health insurance coverage for adults with diabetes. Diabetes Care. 1999;22(10):1679–82.PubMedCrossRef
71.
Beckles GL, Engelgau MM, Narayan KM, Herman WH, Aubert RE, Williamson DF. Population-based assessment of the level of care among adults with diabetes in the U.S. Diabetes Care. 1998;21(9):1432–8.PubMedCrossRef
72.
Gregg EW, Geiss LS, Saaddine J, Fagot-Campagna A, Beckles G, Parker C et al. Use of diabetes preventive care and complications risk in two African-American communities. Am J Prev Med. 2001;21(3):197–202. doi:S074937970100351​8.
73.
Baker RS, Watkins NL, Wilson MR, Bazargan M, Flowers CW, Jr. Demographic and clinical characteristics of patients with diabetes presenting to an urban public hospital ophthalmology clinic. Ophthalmology. 1998;105(8):1373–9. doi:S0161-6420(98)98015-0.
74.
Pugh JA, Tuley MR, Hazuda HP, Stern MP. The influence of outpatient insurance coverage on the microvascular complications of non-insulin-dependent diabetes in Mexican Americans. J Diabetes Complications. 1992;6(4):236–41.PubMedCrossRef
75.
Thackeray R, Merrill RM, Neiger BL. Disparities in diabetes management practice between racial and ethnic groups in the United States. Diabetes Educ. 2004;30(4):665–75.PubMedCrossRef
76.
Ricci-Cabello I, Ruiz-Perez I. Olry de Labry-Lima A, Marquez-Calderon S. Do social inequalities exist in terms of the prevention, diagnosis, treatment, control and monitoring of diabetes? A systematic review. Health Soc Care Community. 2010;18(6):572–87.PubMedCrossRef
77.
78.
Peek ME, Cargill A, Huang ES. Diabetes health disparities: a systematic review of health care interventions. Med Care Res Rev. 2007;64(5 Suppl):101S–56S.PubMedCrossRef
79.
Baig AA, Wilkes AE, Davis AM, Peek ME, Huang ES, Bell DS, et al. The use of quality improvement and health information technology approaches to improve diabetes outcomes in African American and Hispanic patients. Med Care Res Rev. 2010;67(5 Suppl):163S–97S. doi:10.​1177/​1077558710374621​.PubMedCrossRef
Metadaten
Titel
Race/Ethnic Difference in Diabetes and Diabetic Complications
verfasst von
Elias K. Spanakis
Sherita Hill Golden
Publikationsdatum
01.12.2013
Verlag
Springer US
Erschienen in
Current Diabetes Reports / Ausgabe 6/2013
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-013-0421-9

Weitere Artikel der Ausgabe 6/2013

Current Diabetes Reports 6/2013 Zur Ausgabe

Diabetes Epidemiology (SH Golden, Section Editor)

The Emerging Global Epidemic of Type 1 Diabetes

Psychosocial Aspects (KK Hood, Section Editor)

Transition Readiness in Adolescents and Emerging Adults with Diabetes: The Role of Patient-Provider Communication

Genetics (TM Frayling, Section Editor)

Bridging the Gap Between Genetic Associations and Molecular Mechanisms for Type 2 Diabetes

Psychosocial Aspects (KK Hood, Section Editor)

Psychological Care in a National Health Service: Challenges for People with Diabetes

Genetics (TM Frayling, Section Editor)

What the Genetics of Lipodystrophy Can Teach Us About Insulin Resistance and Diabetes

Psychosocial Aspects (KK Hood, Section Editor)

Technology to Optimize Pediatric Diabetes Management and Outcomes

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

10.05.2024 Periphere arterielle Verschlusskrankheit Nachrichten

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise